Seeking Alpha·5d ago
IperionX Limited (IPX) Shareholder/Analyst Call TranscriptIperionX Limited (IPX) Shareholder/Analyst Call Transcript
IperionX is currently in a high-risk, pre-revenue development phase, aggressively deploying capital to scale its proprietary HAMR technology at the Virginia Titanium Demonstration Facility.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Sep 29, 2026 | -$0.09-24.1% vs -$0.07 | — vs $1M |
Q2 2026 Mar 12, 2026 | -$0.10-150.0% vs -$0.04 | — vs $4M |
Q4 2025 Oct 3, 2025 | -$1.20-2298.9% vs -$0.05 | — vs $1M |
Q4 2025 Sep 30, 2025 | -$0.06-20.0% vs -$0.05 | — vs $1M |
IperionX Limited (IPX) Shareholder/Analyst Call Transcript
SOUTH BOSTON, Va., Oct. 29, 2026 (GLOBE NEWSWIRE) -- IperionX Limited (NASDAQ: IPX, ASX: IPX) (IperionX) is pleased to invite shareholders and investors to a webinar on Tuesday, November 3, 2026 at 10:00 am Australian Eastern Daylight Time / Monday, November 2, 2026 at 18:00 pm U.S. Eastern Standard Time , where Founder and CEO, Taso Arima will provide a company update.
CHICAGO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Investment Property Exchange Services, Inc. (IPX1031), the national leader in 1031 Exchange services, today unveiled its 2026 “Happy 10-31 Day” video, ahead of 10-31 Day on October 31, bringing a spirited new character to its annual October 31 celebration. This year's animated adventure follows IPX Jack, a glowing jack-o'-lantern with a mischievous grin, as he rolls through a Halloween landscape and into the world of investment real estate.
IperionX Limited Sponsored ADR (NASDAQ: IPX - Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday. The stock traded as low as $14.60 and last traded at $14.68, with a volume of 317,743 shares traded. The stock had previously closed at $15.62. Analyst Upgrades and Downgrades Several research firms have recently
Benchmark IPX against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for IperionX Limited (IPX)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $14.10 | $47.32M | -0.71 | — | — | -74.21% | — | |
| $4.37 | $177.42M | 8.17 | 55.25% | 58.87% | 6.24% | 23.45% | |
| $1.64 | $48.37M | -1.29 | -86.14% | -34891.94% | -75.37% | — | |
| $1.62 | $113.99M | -3.76 | -22.29% | -12.04% | — | — | |
| $175.79 | $23.99B | 43.79 | 5.16% | 11.08% | 28.01% | — | |
| $278.31 | $13.83B | 24.42 | 8.59% | 17.87% | 26.93% | 0.29% |
IperionX Limited (IPX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when IPX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
IperionX Limited (IPX) stock FAQ — growth, dividends, profitability & financials explained
No. IperionX Limited (IPX) reported a net loss of $67.1M in fiscal year 2026.
IperionX Limited (IPX) had a return on equity (ROE) of -74.2% in fiscal year 2026. A negative ROE means the company lost money over the period.
IperionX Limited (IPX) had negative free cash flow of $63.0M in fiscal year 2026.
